Fresenius Medical Care AG Research And Development Expense

• Fresenius Medical Care AG showed a decrease of -13.9% in Research And Development Expense from 2024 to 2025.
• This data is from Fresenius Medical Care AG's annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 19 years of available data (2007 to 2025), Fresenius Medical Care AG's Research And Development Expense has grown by 137.5%.
• Historical annual values: Fiscal year 2025: $157.98 million | Fiscal year 2024: $183.49 million | Fiscal year 2023: $231.97 million | Fiscal year 2022: $228.62 million | Fiscal year 2021: $220.78 million | Fiscal year 2020: $193.77 million | Fiscal year 2019: $168.03 million | Fiscal year 2018: $114.07 million | Fiscal year 2017: $111.00 million | Fiscal year 2016: $146.51 million | Fiscal year 2015: $128.13 million | Fiscal year 2014: $122.11 million | Fiscal year 2013: $125.81 million | Fiscal year 2012: $111.63 million | Fiscal year 2011: $110.83 million | Fiscal year 2010: $96.53 million | Fiscal year 2009: $93.81 million | Fiscal year 2008: $80.24 million | Fiscal year 2007: $66.52 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026